BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19582519)

  • 1. An analysis of trends and growth factor receptor expression of GI carcinoid tumors.
    Bowen KA; Silva SR; Johnson JN; Doan HQ; Jackson LN; Gulhati P; Qiu S; Riall TS; Evers BM
    J Gastrointest Surg; 2009 Oct; 13(10):1773-80. PubMed ID: 19582519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors.
    Al-Khafaji B; Noffsinger AE; Miller MA; DeVoe G; Stemmermann GN; Fenoglio-Preiser C
    Hum Pathol; 1998 Sep; 29(9):992-9. PubMed ID: 9744317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
    Cai YC; Banner B; Glickman J; Odze RD
    Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal carcinoid tumors: factors that predict outcome.
    Van Gompel JJ; Sippel RS; Warner TF; Chen H
    World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
    Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
    Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tyrosine kinase receptors in malignant midgut carcinoid tumors.
    Welin S; Fjällskog ML; Saras J; Eriksson B; Janson ET
    Neuroendocrinology; 2006; 84(1):42-8. PubMed ID: 17047316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin.
    Jaffee IM; Rahmani M; Singhal MG; Younes M
    Arch Pathol Lab Med; 2006 Oct; 130(10):1522-6. PubMed ID: 17090195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 5-decade analysis of 13,715 carcinoid tumors.
    Modlin IM; Lye KD; Kidd M
    Cancer; 2003 Feb; 97(4):934-59. PubMed ID: 12569593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids.
    Krishnamurthy S; Dayal Y
    Am J Surg Pathol; 1997 Mar; 21(3):327-33. PubMed ID: 9060603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?
    Modlin IM; Lye KD; Kidd M
    Am J Gastroenterol; 2004 Jan; 99(1):23-32. PubMed ID: 14687136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas.
    Papouchado B; Erickson LA; Rohlinger AL; Hobday TJ; Erlichman C; Ames MM; Lloyd RV
    Mod Pathol; 2005 Oct; 18(10):1329-35. PubMed ID: 15920550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531).
    Mocellin S; Nitti D
    Ann Oncol; 2013 Dec; 24(12):3040-4. PubMed ID: 24050954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors and carcinoid tumours.
    Nilsson O; Wängberg B; McRae A; Dahlström A; Ahlman H
    Acta Oncol; 1993; 32(2):115-24. PubMed ID: 8323752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.
    Perez EA; Koniaris LG; Snell SE; Gutierrez JC; Sumner WE; Lee DJ; Hodgson NC; Livingstone AS; Franceschi D
    World J Surg; 2007 May; 31(5):1022-30. PubMed ID: 17429568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin and carcinoid tumors.
    Ahlman H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S79-85. PubMed ID: 2412066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
    Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
    Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated population-based review of carcinoid tumors.
    Maggard MA; O'Connell JB; Ko CY
    Ann Surg; 2004 Jul; 240(1):117-22. PubMed ID: 15213627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis.
    Silva SR; Bowen KA; Rychahou PG; Jackson LN; Weiss HL; Lee EY; Townsend CM; Evers BM
    Int J Cancer; 2011 Mar; 128(5):1045-56. PubMed ID: 20473929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different beta-catenin immunoexpression in carcinoid tumors of the appendix in comparison to other gastrointestinal carcinoid tumors.
    Barshack I; Goldberg I; Chowers Y; Horowitz A; Kopolovic J
    Pathol Res Pract; 2002; 198(8):531-6. PubMed ID: 12389996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.
    Janson ET; Holmberg L; Stridsberg M; Eriksson B; Theodorsson E; Wilander E; Oberg K
    Ann Oncol; 1997 Jul; 8(7):685-90. PubMed ID: 9296223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.